The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
- Key:
- Implementing APCD
- Investigating APCD
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
- Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
H 2573 (repalced by H 4639) – Massachusetts
Introduced: 2018 Status: Inactive / Dead
Senate, June 21, 2018 – Text of the Senate amendment (Senator Welch) to the House Bill establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the …
H 4333 (replaced by H 4605) – Massachusetts
Introduced: 2018 Status: Inactive / Dead
An Act to require written notice of medical tests outside a patient’s network for insurance purposes
H 4112 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT RELATIVE TO PATIENT SAFETY AND HOSPITAL TRANSPARENCY : Initiative petition of Patricia K. Duffy and others for the passage of An Act relative to patient safety and hospital transparency.
H 4113 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT RELATIVE TO PATIENT SAFETY AND HOSPITAL TRANSPARENCY : Initiative petition of Donna Kelly-Williams and others for the passage of An Act relative to patient safety and hospital transparency.
H 4639 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT ESTABLISHING THE HONORABLE PETER V. KOCOT ACT TO ENHANCE ACCESS TO HIGH QUALITY, AFFORDABLE AND TRANSPARENT HEALTHCARE IN THE COMMONWEALTH.
Next | See all Legislation Records
Introduced: 2018 Status: Inactive / Dead
Senate, June 21, 2018 – Text of the Senate amendment (Senator Welch) to the House Bill establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the …
H 4333 (replaced by H 4605) – Massachusetts
Introduced: 2018 Status: Inactive / Dead
An Act to require written notice of medical tests outside a patient’s network for insurance purposes
H 4112 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT RELATIVE TO PATIENT SAFETY AND HOSPITAL TRANSPARENCY : Initiative petition of Patricia K. Duffy and others for the passage of An Act relative to patient safety and hospital transparency.
H 4113 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT RELATIVE TO PATIENT SAFETY AND HOSPITAL TRANSPARENCY : Initiative petition of Donna Kelly-Williams and others for the passage of An Act relative to patient safety and hospital transparency.
H 4639 – Massachusetts
Introduced: 2018 Status: Inactive / Dead
AN ACT ESTABLISHING THE HONORABLE PETER V. KOCOT ACT TO ENHANCE ACCESS TO HIGH QUALITY, AFFORDABLE AND TRANSPARENT HEALTHCARE IN THE COMMONWEALTH.
Next | See all Legislation Records
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
News & Opinions





Articles & Reports
New England Journal of Medicine February 14, 2019
JAMA Internal Medicine January 22, 2019
The Commonwealth Fund January 18, 2019
New England Journal of Medicine January 16, 2019
JAMA Internal Medicine January 22, 2019
The Commonwealth Fund January 18, 2019
New England Journal of Medicine January 16, 2019